Gonçalo Outeiro-Pinho and Daniela Barros-Silva are joint first authors.

Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal

Gonçalo Outeiro-Pinho, Daniela Barros-Silva, Elena Aznar, Ana-Isabel Sousa, Márcia Vieira-Coimbra, Rui Henrique & Carmen Jerónimo

Master in Molecular Medicine and Oncology, Faculty of Medicine-University of Porto (FMUP), Porto, Portugal

Gonçalo Outeiro-Pinho

Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Camino de Vera s/n, 46022, Valencia, Spain

Elena Aznar

Department of Urology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António, Bernardino de Almeida, 4200-072, Porto, Portugal

Jorge Oliveira

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, Braga, Portugal

Céline S. Gonçalves & Bruno M. Costa

ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, University of Minho, Campus de Gualtar, Braga, Portugal

Céline S. Gonçalves & Bruno M. Costa

Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany

Kerstin Junker

Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal

Rui Henrique

Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Rua de Jorge Viterbo Ferreira n. 228, 4050-313, Porto, Portugal

Rui Henrique & Carmen Jerónimo